Federal Appellate Court Sides With Pharmaceutical Company In Finding No Antitrust Violations In Delay Of Generic Drug Deals
Forest Laboratories, the brand manufacturer of the high-blood-pressure drug Bystolic, settled patent-infringement litigation that it brought against seven manufacturers of generic versions of Bystolic. Contemporaneously with eachsettlement, pursuant to which the generic manufacturers agreed to forgo[...]